An ovine-growth-hormone transgene model suitable for selection experiments for growth in mice*

Standing genetic variation and compensatory evolution in transgenic organisms: a growth-enhanced salmon simulation

Genetically modified strains usually are generated within defined genetic backgrounds to minimize variation for the engineered characteristic in order to facilitate basic research investigations or for commercial application. However, interactions between transgenes and genetic background have been documented in both model and commercial agricultural species, indicating that allelic variation at transgene-modifying loci are not uncommon in genomes. Engineered organisms that have the potential to allow entry of transgenes into natural populations may cause changes to ecosystems via the interaction of their specific phenotypes with ecosystem components and services. A transgene introgressing through natural populations is likely to encounter a range of natural genetic variation (among individuals or sub-populations) that could result in changes in phenotype, concomitant with effects on fitness and ecosystem consequences that differ from that seen in the progenitor transgenic strain. In the present study, using a growth hormone transgenic salmon example, we have modeled selection of modifier loci (single and multiple) in the presence of a transgene and have found that accounting for genetic background can significantly affect the persistence of transgenes in populations, potentially reducing or reversing a "Trojan gene" effect. Influences from altered life history characteristics (e.g., developmental timing, age of maturation) and compensatory demographic/ecosystem controls (e.g., density dependence) also were found to have a strong influence on transgene effects. Further, with the presence of a transgene in a population, genetic backgrounds were found to shift in non-transgenic individuals as well, an effect expected to direct phenotypes away from naturally selected optima. The present model has revealed the importance of understanding effects of selection for background genetics on the evolution of phenotypes in populations harbouring transgenes.

Correlated responses to selection for large body size in oMt1a-oGH transgenic mice: organ traits

The objective of the present study was to compare correlated responses in liver, spleen, kidney, heart and testis absolute weights and as a percentage of 8-week body weight following selection for large 8-week body weight in twice-replicated nontransgenic and transgene-carrier lines of mice from two genetic backgrounds. The transgene was an ovine metallothionein 1a-ovine growth hormone (oMt1a-oGH) construct, which was activated by adding 25 mM ZnSO4 to the drinking water. Lines NM and NC were nontransgenic lines derived from a high-growth and randomly selected background, respectively. Lines TM and TC were transgene-carrier lines formed from the respective genetic backgrounds. Line CC was a nontransgenic control from the randomly selected background. At weaning, male mice from each line were assigned to either zinc supplemented or control drinking water. Toe-clips were assayed by PCR for the presence or absence of the transgene. Correlated responses of absolute weights of all organs in nontransgenic lines indicated moderately high genetic correlations of organ weights with body weight, but on a percentage of body weight basis, the correlated responses were much lower. The correlated responses in visceral organ weights were lower in the presence of the inactivated oMt1a-oGH transgene than in its absence. The presence of the activated oMt1a-oGH combined with the effects of selection for growth increase had a greater impact on increasing the size of the splanchnic organs than did selection for large body weight in the absence of the transgene.

Genetic modification of animals in the next century

Since the initial demonstration in 1982 of profound phenotypic effects stemming from the expression of a single transgene, genetic engineering has revolutionized fundamental biological and biomedical research. The application of transgenic technology to farm animals has held the promise of being able to improve animal agriculture significantly and has resulted in a new industry, i.e., the successful expression of foreign proteins in the mammary gland for the pharmaceutical industry. Work over the last few years in model species (e.g., the mouse) and new technical developments such as cloning have now set the stage for the initial application of transgenic technology for the improvement of farm animals. Major limitations that remain are the lack understanding of which genes we should transfer in order to alter quantitative production traits usefully and the low efficiency of producting transgenic founders. Furthermore, more research is needed concerning the consequences and potential problems arising from the integration of transgenes into populations with varying genetic backgrounds. Recent advances suggest that within the first decade of the 21 st century the first transgenic animals will become available to the livestock industry, with acceptance depending upon their cost versus their potential economic benefit to the producers.